Apyx Medical Inc
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and abla… Read more
Apyx Medical Inc (APYX) - Total Assets
Latest total assets as of September 2025: $57.37 Million USD
Based on the latest financial reports, Apyx Medical Inc (APYX) holds total assets worth $57.37 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Apyx Medical Inc - Total Assets Trend (1995–2024)
This chart illustrates how Apyx Medical Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Apyx Medical Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Apyx Medical Inc's total assets of $57.37 Million consist of 87.0% current assets and 13.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 49.0% |
| Accounts Receivable | $15.48 Million | 23.9% |
| Inventory | $7.56 Million | 11.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1995–2024)
This chart illustrates how Apyx Medical Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Apyx Medical Inc's current assets represent 87.0% of total assets in 2024, an increase from 46.7% in 1995.
- Cash Position: Cash and equivalents constituted 49.0% of total assets in 2024, up from 4.6% in 1995.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 14.0% in 1995.
- Asset Diversification: The largest asset category is accounts receivable at 23.9% of total assets.
Apyx Medical Inc Competitors by Total Assets
Key competitors of Apyx Medical Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Apyx Medical Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Apyx Medical Inc generates 0.74x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Apyx Medical Inc is currently not profitable relative to its asset base.
Apyx Medical Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.44 | 5.46 | 7.22 |
| Quick Ratio | 3.61 | 4.52 | 6.78 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $37.81 Million | $ 42.60 Million | $ 56.94 Million |
Apyx Medical Inc - Advanced Valuation Insights
This section examines the relationship between Apyx Medical Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 24.11 |
| Latest Market Cap to Assets Ratio | 1.52 |
| Asset Growth Rate (YoY) | -18.2% |
| Total Assets | $64.84 Million |
| Market Capitalization | $98.75 Million USD |
Valuation Analysis
Above Book Valuation: The market values Apyx Medical Inc's assets above their book value (1.52 x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Apyx Medical Inc's assets decreased by 18.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Apyx Medical Inc (1995–2024)
The table below shows the annual total assets of Apyx Medical Inc from 1995 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $64.84 Million | -18.17% |
| 2023-12-31 | $79.24 Million | +53.05% |
| 2022-12-31 | $51.77 Million | -24.66% |
| 2021-12-31 | $68.72 Million | -7.27% |
| 2020-12-31 | $74.11 Million | -12.48% |
| 2019-12-31 | $84.68 Million | -11.44% |
| 2018-12-31 | $95.61 Million | +208.54% |
| 2017-12-31 | $30.99 Million | -11.74% |
| 2016-12-31 | $35.11 Million | +11.64% |
| 2015-12-31 | $31.45 Million | +26.64% |
| 2014-12-31 | $24.83 Million | -25.15% |
| 2013-12-31 | $33.18 Million | +17.72% |
| 2012-12-31 | $28.18 Million | -0.20% |
| 2011-12-31 | $28.24 Million | +1.63% |
| 2010-12-31 | $27.79 Million | +0.73% |
| 2009-12-31 | $27.58 Million | +7.00% |
| 2008-12-31 | $25.78 Million | +36.97% |
| 2007-12-31 | $18.82 Million | +12.80% |
| 2006-12-31 | $16.69 Million | +41.75% |
| 2005-12-31 | $11.77 Million | +6.82% |
| 2004-12-31 | $11.02 Million | +19.33% |
| 2003-12-31 | $9.23 Million | +8.62% |
| 2002-12-31 | $8.50 Million | -0.91% |
| 2001-12-31 | $8.58 Million | +8.40% |
| 2000-12-31 | $7.91 Million | +7.76% |
| 1999-12-31 | $7.34 Million | -31.11% |
| 1998-12-31 | $10.66 Million | +177.77% |
| 1997-12-31 | $3.84 Million | -1.57% |
| 1996-12-31 | $3.90 Million | +8.28% |
| 1995-12-31 | $3.60 Million | -- |